• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者中载脂蛋白A-I糖基化升高与高密度脂蛋白相关对氧磷酶1、3活性降低的关联及其与冠状动脉疾病血管造影严重程度的相互作用。

Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.

作者信息

Shen Ying, Ding Feng Hua, Sun Jia Teng, Pu Li Jin, Zhang Rui Yan, Zhang Qi, Chen Qiu Jing, Shen Wei Feng, Lu Lin

机构信息

Department of Cardiology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, 197 Rui Jin Road II, Shanghai, 200025, People's Republic of China.

Institute of Cardiovascular Disease, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.

出版信息

Cardiovasc Diabetol. 2015 May 13;14:52. doi: 10.1186/s12933-015-0221-4.

DOI:10.1186/s12933-015-0221-4
PMID:25964115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4432963/
Abstract

OBJECTIVE

To investigate whether apolipoprotein A (apoA)-I glycation and paraoxonase (PON) activities are associated with the severity of coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM).

METHODS

Relative intensity of apoA-I glycation and activities of high-density lipoprotein (HDL)-associated PON1 and PON3 were determined in 205 consecutive T2DM patients with stable angina with (n = 144) or without (n = 61) significant CAD (luminal diameter stenosis ≥ 70 %). The severity of CAD was expressed by number of diseased coronary arteries, extent index, and cumulative coronary stenosis score (CCSS).

RESULTS

The relative intensity of apoA-I glycation was higher but the activities of HDL-associated PON1 and PON3 were lower in diabetic patients with significant CAD than in those without. The relative intensity of apoA-I glycation increased but the activities of HDL-associated PON1 and PON3 decreased stepwise from 1 - to 3 - vessel disease patients (P for trend < 0.001). After adjusting for possible confounding variables, the relative intensity of apoA-I glycation correlated positively, while the activities of HDL-associated PON1 and PON3 negatively, with extent index and CCSS, respectively. At high level of apoA-I glycation (8.70 ~ 12.50 %), low tertile of HDL-associated PON1 (7.03 ~ 38.97U/mL) and PON3 activities (7.11 ~ 22.30U/mL) was associated with a 1.97- and 2.49- fold increase of extent index and 1.73- and 2.68- fold increase of CCSS compared with high tertile of HDL-associated PON1 (57.85 ~ 154.82U/mL) and PON3 activities (39.63 ~ 124.10U/mL), respectively (all P < 0.01).

CONCLUSIONS

Elevated apoA-I glycation and decreased activities of HDL-associated PON1 and PON3, and their interaction are associated with the presence and severity of CAD in patients with T2DM.

摘要

目的

研究载脂蛋白A(apoA)-I糖基化及对氧磷酶(PON)活性是否与2型糖尿病(T2DM)患者冠状动脉疾病(CAD)的严重程度相关。

方法

对205例连续性稳定型心绞痛的T2DM患者进行检测,其中有严重CAD(管腔直径狭窄≥70%)的患者144例,无严重CAD的患者61例。测定apoA-I糖基化的相对强度以及高密度脂蛋白(HDL)相关的对氧磷酶1(PON1)和对氧磷酶3(PON3)的活性。CAD的严重程度用病变冠状动脉数量、范围指数和累积冠状动脉狭窄评分(CCSS)表示。

结果

有严重CAD的糖尿病患者apoA-I糖基化的相对强度较高,但HDL相关的PON1和PON3活性较低。从单支血管病变到三支血管病变患者,apoA-I糖基化的相对强度升高,而HDL相关的PON1和PON3活性逐步降低(趋势P<0.001)。在调整可能的混杂变量后,apoA-I糖基化的相对强度分别与范围指数和CCSS呈正相关,而HDL相关的PON1和PON3活性分别与范围指数和CCSS呈负相关。在apoA-I糖基化高水平(8.7012.50%)时,HDL相关的PON1低三分位数(7.0338.97U/mL)和PON3活性(7.1122.30U/mL)与范围指数分别增加1.97倍和2.49倍、CCSS分别增加1.73倍和2.68倍相关,而HDL相关的PON1高三分位数(57.85154.82U/mL)和PON3活性(39.63~124.10U/mL)时与之相比(所有P<0.01)。

结论

apoA-I糖基化升高、HDL相关的PON1和PON3活性降低及其相互作用与T2DM患者CAD的存在及严重程度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abf/4432963/2a398c5d2d17/12933_2015_221_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abf/4432963/2a398c5d2d17/12933_2015_221_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abf/4432963/2a398c5d2d17/12933_2015_221_Fig1_HTML.jpg

相似文献

1
Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.2型糖尿病患者中载脂蛋白A-I糖基化升高与高密度脂蛋白相关对氧磷酶1、3活性降低的关联及其与冠状动脉疾病血管造影严重程度的相互作用。
Cardiovasc Diabetol. 2015 May 13;14:52. doi: 10.1186/s12933-015-0221-4.
2
Low serum paraoxonase1 activity levels predict coronary artery disease severity.血清对氧磷酶1活性水平低预示冠状动脉疾病的严重程度。
Oncotarget. 2017 Mar 21;8(12):19443-19454. doi: 10.18632/oncotarget.14305.
3
Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.2 型糖尿病患者的髓过氧化物酶和对氧磷酶-1。
Nutr Metab Cardiovasc Dis. 2009 Nov;19(9):613-9. doi: 10.1016/j.numecd.2008.12.005. Epub 2009 Feb 6.
4
Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.安塔利亚地区经血管造影证实患有冠状动脉疾病的人群中对氧磷酶-1活性与脂质过氧化指标水平之间的关联。
Clin Cardiol. 2004 Jul;27(7):426-30. doi: 10.1002/clc.4960270714.
5
Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.低对氧磷酶1芳基酯酶活性和高血管性血友病因子水平与非糖尿病稳定型冠心病患者的严重冠状动脉粥样硬化相关。
Med Sci Monit. 2014 Nov 25;20:2421-9. doi: 10.12659/MSM.890911.
6
HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.经血管造影证实患有冠状动脉疾病的患者中不含载脂蛋白A-II(LpA-I)的含载脂蛋白A-I的高密度脂蛋白亚群。
J Cardiol. 2017 Mar;69(3):523-528. doi: 10.1016/j.jjcc.2016.04.007. Epub 2016 May 8.
7
Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.血清髓过氧化物酶/对氧磷酶1比值作为冠状动脉疾病中功能失调的高密度脂蛋白和风险分层的潜在指标。
Atherosclerosis. 2014 Jun;234(2):288-94. doi: 10.1016/j.atherosclerosis.2014.03.009. Epub 2014 Mar 19.
8
High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.血清对氧磷酶PON1与载脂蛋白A-I锚定在高密度脂蛋白上时的高亲和力、稳定性及内酯酶活性。
Biochemistry. 2005 Sep 6;44(35):11843-54. doi: 10.1021/bi050862i.
9
Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects.在2型糖尿病患者和非糖尿病患者中,血清对氧磷酶-1活性与高密度脂蛋白(HDL)颗粒浓度及大HDL颗粒的关系,比与HDL胆固醇的关系更为密切。
Clin Biochem. 2014 Aug;47(12):1022-7. doi: 10.1016/j.clinbiochem.2014.04.013. Epub 2014 Apr 21.
10
Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality.通过替代载脂蛋白 1 活性来评估冠心病风险:基于高密度脂蛋白功能的新型代谢相关心血管生物标志物。
Nutr Metab Cardiovasc Dis. 2021 Apr 9;31(4):1166-1176. doi: 10.1016/j.numecd.2020.12.026. Epub 2021 Jan 1.

引用本文的文献

1
Use of Olives-derived Phytochemicals for Prevention and Treatment of Atherosclerosis: An Update.利用橄榄衍生植物化学物质预防和治疗动脉粥样硬化:最新进展。
Curr Top Med Chem. 2024;24(25):2173-2190. doi: 10.2174/0115680266314560240806101445.
2
High-Density Lipoprotein Modifications: Causes and Functional Consequences in Type 2 Diabetes Mellitus.高密度脂蛋白修饰:2 型糖尿病中的病因和功能后果。
Cells. 2024 Jun 27;13(13):1113. doi: 10.3390/cells13131113.
3
Synergistic Anti-Inflammatory Activity of Lipid-Free Apolipoprotein (apo) A-I and CIGB-258 in Acute-Phase Zebrafish via Stabilization of the apoA-I Structure to Enhance Anti-Glycation and Antioxidant Activities.

本文引用的文献

1
[Is paraoxonase 1 a marker of cardiovascular risk in youth with type 1 diabetes? (Study about 109 cases)].
Presse Med. 2015 May;44(5):e185-90. doi: 10.1016/j.lpm.2014.10.020. Epub 2015 Mar 11.
2
Q192R polymorphism of paraoxonase 1 gene associated with insulin resistance in Mexican children.载脂蛋白 1 基因 Q192R 多态性与墨西哥儿童胰岛素抵抗相关。
Arch Med Res. 2015 Jan;46(1):78-83. doi: 10.1016/j.arcmed.2014.12.001. Epub 2014 Dec 10.
3
Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease.血清视黄醇结合蛋白-4水平与冠状动脉疾病的存在及严重程度相关。
载脂蛋白 A-I(apoA-I)与 CIGB-258 的协同抗炎活性:稳定 apoA-I 结构以增强抗糖基化和抗氧化活性的急性相斑马鱼模型
Int J Mol Sci. 2024 May 20;25(10):5560. doi: 10.3390/ijms25105560.
4
PRP of T2DM Patient Immobilized on PCL Nanofibers Stimulate Endothelial Cells Proliferation.糖尿病患者的血小板衍生生长因子固定在聚己内酯纳米纤维上可刺激内皮细胞增殖。
Int J Mol Sci. 2023 May 5;24(9):8262. doi: 10.3390/ijms24098262.
5
Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies.慢性炎症性疾病患者中高密度脂蛋白(HDL)向前β高密度脂蛋白(piHDL)蛋白质组的改变以及针对HDL的疗法
Pharmaceuticals (Basel). 2022 Oct 18;15(10):1278. doi: 10.3390/ph15101278.
6
Differences in HDL-Bound Apolipoproteins in Patients With Advanced Liver Fibrosis Due to Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病导致的晚期肝纤维化患者高密度脂蛋白结合载脂蛋白的差异。
J Clin Endocrinol Metab. 2022 Dec 17;108(1):42-51. doi: 10.1210/clinem/dgac565.
7
[Dysfunctional high-density lipoproteins in diabetes mellitus].[糖尿病中的功能失调高密度脂蛋白]
Probl Endokrinol (Mosk). 2022 Jun 10;68(4):69-77. doi: 10.14341/probl13118.
8
Diabetic dyslipidemia impairs coronary collateral formation: An update.糖尿病血脂异常损害冠状动脉侧支循环形成:最新进展。
Front Cardiovasc Med. 2022 Aug 22;9:956086. doi: 10.3389/fcvm.2022.956086. eCollection 2022.
9
The Relationship between Cancer and Paraoxonase 1.癌症与对氧磷酶1之间的关系
Antioxidants (Basel). 2022 Mar 31;11(4):697. doi: 10.3390/antiox11040697.
10
Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis.对冠心病患者的对氧磷酶-1(PON-1)芳基酯酶活性水平的荟萃分析。
Dis Markers. 2022 Mar 10;2022:4264314. doi: 10.1155/2022/4264314. eCollection 2022.
Cardiovasc Diabetol. 2014 Aug 21;13:121. doi: 10.1186/s12933-014-0121-z.
4
The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients.无症状2型糖尿病患者血清缺氧诱导因子1α与冠状动脉钙化的关系
Cardiovasc Diabetol. 2014 Feb 24;13:52. doi: 10.1186/1475-2840-13-52.
5
Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion.血清糖化白蛋白水平升高与稳定型心绞痛和慢性完全闭塞的 2 型糖尿病患者低侧支循环形成相关。
Cardiovasc Diabetol. 2013 Nov 8;12:165. doi: 10.1186/1475-2840-12-165.
6
Therapeutic approaches to the regulation of metabolism of high-density lipoprotein. Novel HDL-directed pharmacological intervention and exercise.高密度脂蛋白代谢调节的治疗方法。新型 HDL 靶向药理学干预和运动。
Circ J. 2013;77(11):2651-63. doi: 10.1253/circj.cj-12-1584. Epub 2013 Oct 10.
7
Cardioprotective functions of HDLs.高密度脂蛋白的心脏保护功能。
J Lipid Res. 2014 Feb;55(2):168-79. doi: 10.1194/jlr.R039297. Epub 2013 Jun 27.
8
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I.糖尿病与血管病变:病理生理学、临床后果与医学治疗:第 1 部分。
Eur Heart J. 2013 Aug;34(31):2436-43. doi: 10.1093/eurheartj/eht149. Epub 2013 May 2.
9
Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study.急性冠状动脉综合征患者中晚期糖基化终产物与斑块进展的关系:JAPAN-ACS 子研究。
Cardiovasc Diabetol. 2013 Jan 7;12:5. doi: 10.1186/1475-2840-12-5.
10
Glycation of apoprotein A-I is associated with coronary artery plaque progression in type 2 diabetic patients.载脂蛋白 A-I 糖基化与 2 型糖尿病患者冠状动脉斑块进展有关。
Diabetes Care. 2013 May;36(5):1312-20. doi: 10.2337/dc12-1411. Epub 2012 Dec 10.